Inbox Health
PrivateLast Round
Growth Equity
Sep 15, 2025
Total Funding Raised
$54.31M
Company Overview
Inbox Health operates in Healthcare & Life Sciences and is based in New Haven, Connecticut. Its latest recorded funding round was a Growth Equity round in September 2025.
Inbox Health is a healthcare technology company that offers a patient billing and communications platform designed to automate and personalize the billing, support, and payment experience for patients and healthcare providers.
Sector
Healthcare & Life Sciences
Verticals
Revenue Cycle, Patient Engagement, Vertical SaaS, Digital Payments, Workflow Automation
Business Model
B2B
Customer Profile
Subscription SaaS, Payment Processing Fee, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inbox Health Comparables
Compare Inbox Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Collectly | 86% | |
| Millennia | 85% | |
| PatientPay | 83% |
For institutional investors. Book with your work email.
Inbox Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Sep 15, 2025 | ||||
| Series B | May 4, 2023 | ||||
| Series A | Apr 5, 2021 | ||||
| VC Round | Mar 10, 2020 | ||||
| Seed | Jun 26, 2019 | ||||
Seed | Jul 2, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Inbox Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| I2BF Global Ventures | Series A, VC Round, Seed, Growth Equity |
| Ten Coves Capital | Growth Equity, Series B |
| Connecticut Innovations | Series A, VC Round, Growth Equity, Series B, Seed |
| Commerce Ventures | VC Round, Series B, Series A |
| Commerce Ventures | VC Round, Growth Equity, Series B, Series A |
| Fairview Capital | Series A, Growth Equity, Series B |
| Collaborative Fund | Series A, VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 28, 2026
Named to the Inc. 5000 list of fastest-growing private companies.
- Feb 23, 2026
Established as a preferred patient payments partner for UrgentIQ.
For institutional investors. Book with your work email.
Inbox Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Inbox Health's valuation, stock price, and market status.
Is Inbox Health a public or private company?
Inbox Health is a private company.
What is the current stock price of Inbox Health?
Inbox Health is a private company, so its shares have no public market price. Caplight tracks Inbox Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Inbox Health worth (valuation)?
Valuation information for Inbox Health is not publicly available.
Can I buy Inbox Health stock?
Inbox Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Inbox Health's last funding round?
Inbox Health's most recent funding round was Growth Equity on September 15, 2025.
Who are the main investors in Inbox Health?
Key investors in Inbox Health include Ten Coves Capital, Connecticut Innovations, Commerce Ventures, Commerce Ventures, Healthy Ventures.
Will Inbox Health IPO soon?
No public IPO plans have been announced for Inbox Health.
How can I track Inbox Health secondary market activity?
Caplight tracks bids, offers, and trades in Inbox Health's shares on secondary markets.